Predicting DNA damage foci and their experimental readout with 2D microscopy: a unified approach applied to photon and neutron exposures.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
30 09 2019
Historique:
received: 18 02 2019
accepted: 05 09 2019
entrez: 2 10 2019
pubmed: 2 10 2019
medline: 3 11 2020
Statut: epublish

Résumé

The consideration of how a given technique affects results of experimental measurements is a must to achieve correct data interpretation. This might be challenging when it comes to measurements on biological systems, where it is unrealistic to have full control (e.g. through a software replica) of all steps in the measurement chain. In this work we address how the effectiveness of different radiation qualities in inducing biological damage can be assessed measuring DNA damage foci yields, only provided that artefacts related to the scoring technique are adequately considered. To this aim, we developed a unified stochastic modelling approach that, starting from radiation tracks, predicts both the induction, spatial distribution and complexity of DNA damage, and the experimental readout of foci when immunocytochemistry coupled to 2D fluorescence microscopy is used. The approach is used to interpret γ-H2AX data for photon and neutron exposures. When foci are reconstructed in the whole cell nucleus, we obtain information on damage characteristics "behind" experimental observations, as the average damage content of a focus. We reproduce how the detection technique affects experimental findings, e.g. contributing to the saturation of foci yields scored at 30 minutes after exposure with increasing dose and to the lack of dose dependence for yields at 24 hours.

Identifiants

pubmed: 31570741
doi: 10.1038/s41598-019-50408-5
pii: 10.1038/s41598-019-50408-5
pmc: PMC6769049
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

14019

Subventions

Organisme : NIBIB NIH HHS
ID : P41 EB002033
Pays : United States
Organisme : U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (NIBIB)
ID : 5 P41 EB002033
Pays : International

Références

Radiat Res. 2011 Dec;176(6):706-15
pubmed: 21797665
Curr Biol. 2000 Jul 27-Aug 10;10(15):886-95
pubmed: 10959836
PLoS One. 2013 Nov 29;8(11):e79541
pubmed: 24312182
Mol Cell. 2009 May 15;34(3):298-310
pubmed: 19450528
Radiat Res. 2014 Sep;182(3):273-81
pubmed: 25076115
Cell. 2005 Dec 29;123(7):1213-26
pubmed: 16377563
Int J Radiat Biol. 1989 Jul;56(1):1-19
pubmed: 2569005
Cancer Lett. 2012 Dec 31;327(1-2):123-33
pubmed: 22198208
PLoS Comput Biol. 2007 Aug;3(8):e155
pubmed: 17676951
Int J Radiat Biol. 2012 Jan;88(1-2):77-86
pubmed: 21957961
Radiat Res. 2013 Nov;180(5):524-38
pubmed: 24138482
Oncotarget. 2017 Nov 25;8(65):109370-109381
pubmed: 29312614
Radiat Res. 2009 Apr;171(4):438-45
pubmed: 19397444
Radiat Environ Biophys. 2008 Feb;47(1):49-61
pubmed: 18193257
PLoS One. 2015 Jun 11;10(6):e0129416
pubmed: 26067661
Radiat Res. 2010 Mar;173(3):263-71
pubmed: 20199211
Radiat Res. 2013 Jun;179(6):690-7
pubmed: 23647004
Radiat Res. 2019 Jul;192(1):1-12
pubmed: 31081741
Sci Rep. 2016 Sep 22;6:34033
pubmed: 27654349
Radiat Environ Biophys. 1999 May;38(1):1-13
pubmed: 10384950
Nat Rev Cancer. 2008 Dec;8(12):957-67
pubmed: 19005492
Mutat Res. 2011 Jun 3;711(1-2):28-40
pubmed: 21281649
Nucl Instrum Methods Phys Res A. 2015 Sep 11;794:234-239
pubmed: 26273118
Radiat Res. 2005 Oct;164(4 Pt 2):518-22
pubmed: 16187760
Mutat Res. 2013 Oct;750(1-2):56-66
pubmed: 23958412
Radiat Prot Dosimetry. 2019 May 1;183(1-2):22-25
pubmed: 30535167
Radiat Res. 2017 Apr;187(4):413-423
pubmed: 28140790
Radiat Oncol. 2009 Aug 24;4:31
pubmed: 19703306
Sci Rep. 2017 Mar 27;7:45161
pubmed: 28345622
Cytometry A. 2013 Nov;83(11):1017-26
pubmed: 24009179
Trends Cell Biol. 2009 May;19(5):207-17
pubmed: 19342239
Oncogene. 2001 Apr 26;20(18):2212-24
pubmed: 11402316
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Science. 2002 May 3;296(5569):922-7
pubmed: 11934988
Sci Rep. 2017 Sep 20;7(1):11923
pubmed: 28931851
Cell. 2011 Mar 4;144(5):732-44
pubmed: 21353298
Cytogenet Genome Res. 2004;104(1-4):14-20
pubmed: 15162010
Int J Radiat Biol. 2018 Aug;94(8):759-768
pubmed: 29219655
Radiat Prot Dosimetry. 2019 May 1;183(1-2):121-125
pubmed: 30520984
Mol Cell Biol. 2011 Dec;31(24):4858-73
pubmed: 22006017
Radiat Res. 2001 Oct;156(4):365-78
pubmed: 11554848
J Instrum. 2012 Mar 16;7(3):
pubmed: 22545061
DNA Repair (Amst). 2004 Aug-Sep;3(8-9):959-67
pubmed: 15279782
Leukemia. 2010 Apr;24(4):679-86
pubmed: 20130602
Int J Mol Sci. 2017 Sep 15;18(9):
pubmed: 28914798
PLoS One. 2015 Jun 24;10(6):e0129438
pubmed: 26107175
Radiat Prot Dosimetry. 2019 May 1;183(1-2):126-130
pubmed: 30535025
J Biol Chem. 1998 Mar 6;273(10):5858-68
pubmed: 9488723
Expert Rev Proteomics. 2005 Oct;2(5):719-29
pubmed: 16209651
Nucleic Acids Res. 2008 Oct;36(17):5678-94
pubmed: 18772227
EMBO J. 2004 Jul 7;23(13):2674-83
pubmed: 15201865
Sci Rep. 2017 Jan 17;7:40616
pubmed: 28094292

Auteurs

Sofia Barbieri (S)

Physics Department, University of Pavia, Pavia, Italy. sofia.barbieri@unipv.it.

Gabriele Babini (G)

Physics Department, University of Pavia, Pavia, Italy.

Jacopo Morini (J)

Physics Department, University of Pavia, Pavia, Italy.

Werner Friedland (W)

Institute of Radiation Medicine, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.

Manuela Buonanno (M)

Center for Radiological Research, Columbia University Medical Center, New York, USA.

Veljko Grilj (V)

Center for Radiological Research, Columbia University Medical Center, New York, USA.

David J Brenner (DJ)

Center for Radiological Research, Columbia University Medical Center, New York, USA.

Andrea Ottolenghi (A)

Physics Department, University of Pavia, Pavia, Italy.

Giorgio Baiocco (G)

Physics Department, University of Pavia, Pavia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH